Palisade Bio registers 8.9M shares for resale by selling stockholders

Published 2 months ago Positive
Palisade Bio registers 8.9M shares for resale by selling stockholders
Auto
* Palisade Bio (NASDAQ:PALI [https://seekingalpha.com/symbol/PALI]) filed to register up to 8.9M shares of common stock for resale by selling stockholders.
* The shares include 8.64M issuable upon exercise of a warrant from a private placement, and 259,134 from placement agent warrants.
* Palisade Bio will not receive any proceeds from the resale of these shares.
* Source: SEC filing [https://seekingalpha.com/filing/10313266]

MORE ON PALISADE BIO

* Seeking Alpha’s Quant Rating on Palisade Bio [https://seekingalpha.com/symbol/PALI/ratings/quant-ratings]
* Historical earnings data for Palisade Bio [https://seekingalpha.com/symbol/PALI/earnings]
* Financial information for Palisade Bio [https://seekingalpha.com/symbol/PALI/income-statement]

More News

ROSEN, LEADING INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

19 minutes ago Positive

Kaltura signals transition to AI-driven CX/EX with eSelf acquisition and targets double-digit revenue growth by 2028

21 minutes ago Positive

Apei outlines $640M-$644M full-year revenue target as enrollment momentum drives Q4 guidance

21 minutes ago Positive

Lexington Law Firm Named Best Credit Repair Company of 2026 Reviews by Tidewater News

27 minutes ago Positive

JSPR DEADLINE ALERT: ROSEN, A TOP-RANKED LAW FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPR

35 minutes ago Positive